Providence Medical Research Center
Spokane, Washington 99208
2 studies enrolling now · 34 studies all time
What they study most
Adult Disease, Any Condition in N73.0 Specified as Chronic, Arthroplasty, Bronchiectasis, COVID-19, Cardiovascular Risk, Celiac Disease, Charcot-Marie-Tooth Disease, Chronic Kidney Disease, Covid19, Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation
Studies at this site
- The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis — Recruiting now
- EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) — Recruiting now
- Nephrotic Syndrome Study Network — Recruiting now
- A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease — Recruiting now
- ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed
- Triathlon Tritanium Cone Augments Outcomes Study — Running, not enrolling
- Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection — Completed
- A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (the REMODEL Trial) — Completed
- RECOVER-VITAL: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID Symptoms — Completed
- ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin) — Completed
- ACTIV-6: COVID-19 Study of Repurposed Medications — Completed
- Safety and Efficacy of NMD670 in Adult Patients With Type 1 and Type 2 Charcot-Marie-Tooth Disease — Completed
- EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin) — Completed
- ACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast) — Completed
- ACTIV-6: COVID-19 Study of Repurposed Medications - Arm E (Fluvoxamine 100) — Completed
- A Study to Test Whether Different Doses of BI 690517 Alone or in Combination With Empagliflozin Improve Kidney Function in People With Chronic Kidney Disease — Completed
- Immune Modulators for Treating COVID-19 — Completed
- Study to Determine the Efficacy&Safety of ARV-1801(ACG-701) for the Treatment of Cystic Fibrosis Pulmonary Exacerbations — Withdrawn before enrolling
- Study of Diroximel Fumarate in the Real-World Setting — Stopped early
- AeroVanc in the Treatment of Methicillin-resistant Staphylococcus Aureus Infection in Patients With Cystic Fibrosis — Completed
- A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease — Stopped early
- An Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney Diseases — Stopped early
- Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting — Stopped early
- The SENTRY Clinical Study — Completed
- Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction — Stopped early
- Open-label Extension of Oral Treprostinil in Subjects With PH Associated With HFpEF — Stopped early
- Feasibility Study of Using Navigational Bronchoscopy to Perform PDT-Photofrin® in Unresectable Peripheral Lung Cancer — Completed
- Pamidronate, Vitamin D, and Calcium for the Bone Disease of Kidney and Heart Transplantation — Completed
- Feasibility Study of the Magnetic Anal Sphincter (FENIX System) — Completed
- Safety of Rt-PA + Transcranial Emission of Low-Energy Lasers for Acute Stroke Recovery — Stopped early
- Celiac Disease and Unexplained Iron Deficiency in a Primary Care Setting — Stopped early
- Medication-taking Preferences & Practices of Patients With Chronic Conditions — Status unconfirmed
- The Heart Institute of Spokane Diet Study — Completed
- Angiotensin II Antagonism of TGF-Beta 1 — Completed